
StayHappi Glimepiride+Metformin 1mg/1000mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (1000mg)
Overview StayHappi Glimepiride+Metformin 1mg/1000mg Tablet
Glimepiride/Metformin 1mg/1000mg tablets, marketed as StayHappi, are oral antidiabetic agents combining two medications to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is one element of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as advised by your doctor. Common side effects include hypoglycemia (low blood sugar). Learn to identify hypoglycemic symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (fast-acting glucose sources like sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential under medical supervision.
Uses of StayHappi Glimepiride+Metformin 1mg/1000mg Tablet
Managing type 2 diabetes
Major Benefits of StayHappi Glimepiride+Metformin 1mg/1000mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the StayHappi Glimepiride+Metformin 1mg/1000mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
Common Side effects of StayHappi Glimepiride+Metformin 1mg/1000mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use StayHappi Glimepiride+Metformin 1mg/1000mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride+Metformin 1mg/1000mg Tablet should be administered with a meal.
How StayHappi Glimepiride+Metformin 1mg/1000mg Tablet works:
StayHappi tablets, containing Glimepiride 1mg and Metformin 1000mg, combine two diabetes medications. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Glimepiride+Metformin 1mg/1000mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin 1mg/1000mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid StayHappi Glimepiride+Metformin 1mg/1000mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with kidney impairment should use StayHappi Glimepiride+Metformin 1mg/1000mg Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. This medication is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use StayHappi Glimepiride+Metformin 1mg/1000mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for patients with severe liver disease.
What if you forget to take StayHappi Glimepiride+Metformin 1mg/1000mg Tablet :
Should you forget a dose of StayHappi Glimepiride+Metformin 1mg/1000mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About StayHappi Glimepiride+Metformin 1mg/1000mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
